Gottschalk; Stephen M. G.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Gottschalk; Stephen M. G..The latest application filed is for "car t-cells recognizing cancer-specific il 13ra2".
- Gottschalk; Stephen M. G. - Houston TX
| Patent | Date |
|---|---|
| Chimeric antigen receptor therapy with reduced cytotoxicity for viral disease Grant 11,219,646 - Kruse , et al. January 11, 2 | 2022-01-11 |
| CAR T-CELLS RECOGNIZING CANCER-SPECIFIC IL 13Ra2 App 20200181227 - BALYASNIKOVA; Irina V. ; et al. | 2020-06-11 |
| Chimeric Antigen Receptor Therapy With Reduced Cytotoxicity For Viral Disease App 20190307798 - Kruse; Robert Layne ; et al. | 2019-10-10 |
| Antibody Based Gene Therapy With Tissue-directed Expression App 20190225673 - Kruse; Robert Layne ; et al. | 2019-07-25 |
| Constitutively Active Cytokine Receptors For Cell Therapy App 20190183936 - Shum, Shum; Thomas C. T. ; et al. | 2019-06-20 |
| Engager Cells For Immunotherapy App 20190117692 - Gottschalk; Stephen M. G. ; et al. | 2019-04-25 |
| Cancer Gene Therapy Targeting Cd47 App 20190119379 - Gottschalk; Stephen M. G. ; et al. | 2019-04-25 |
| CAR T CELLS RECOGNIZING CANCER-SPECIFIC IL 13Ra2 App 20180170992 - Balyasnikova; Irina V. ; et al. | 2018-06-21 |
| Chimeric Cd27 Receptors For Redirecting T Cells To Cd70-positive Malignancies App 20180104337 - Gottschalk; Stephen M.G. ; et al. | 2018-04-19 |
| HER2/ErbB2 Chimeric Antigen Receptor App 20180079824 - Ahmed; Nabil M. ; et al. | 2018-03-22 |
| Glypican-3 Specific Chimeric Antigen Receptors For Adoptive Immunotherapy App 20170281683 - Heczey; Andras ; et al. | 2017-10-05 |
| Immunotherapy Of Cancer Using Genetically Engineered Gd2-specific T Cells App 20170027988 - Brenner; Malcolm ; et al. | 2017-02-02 |
| Immunotherapy of cancer using genetically engineered GD2-specific T cells Grant 9,493,740 - Brenner , et al. November 15, 2 | 2016-11-15 |
| Chemotherapy-resistant Immune Cells App 20160024175 - Chow; Kevin Kwong-Hon ; et al. | 2016-01-28 |
| Vascular-targeted T-cell Therapy App 20160015750 - Gottschalk; Stephen M. G. ; et al. | 2016-01-21 |
| Engager Cells For Immunotherapy App 20160015749 - Gottschalk; Stephen M. G. ; et al. | 2016-01-21 |
| Oncolytic Virus App 20160000842 - Song; Xiao-Tong ; et al. | 2016-01-07 |
| Ebv-specific Cytotoxic T-lymphocytes For The Treatment Of Locoregional Nasopharyngeal Carcinoma (npc) App 20140086888 - Heslop; Helen E. ; et al. | 2014-03-27 |
| Immunotherapy Of Cancer Using Genetically Engineered Gd2-specific T Cells App 20140004132 - Brenner; Malcolm ; et al. | 2014-01-02 |
| Chimeric Cd27 Receptors For Redirecting T Cells To Cd70-positive Malignancies App 20130323214 - Gottschalk; Stephen M.G. ; et al. | 2013-12-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 